Inhibitors of the 90‐ kDa heat shock protein (Hsp90) family, especially Hsp90β, have been a sought‐after therapeutic strategy for the treatment of cancer, neurological disorders, and other diseases. This evidence concerns the gene HSP90AA1 and cancer.